Skip to main content
XBiotech Inc. logo

XBiotech Inc. — Investor Relations & Filings

Ticker · XBIT ISIN · CA98400H1029 LEI · 5299002WACAY28TQAS52 US Manufacturing
Filings indexed 398 across all filing types
Latest filing 2023-04-28 Annual Report
Country US United States of America
Listing US XBIT

About XBiotech Inc.

https://www.xbiotech.com/

XBiotech Inc. is a fully integrated biosciences company focused on the discovery and development of therapeutic antibodies. The company's proprietary True Human™ antibody platform identifies and clones antibodies directly from individuals who possess natural immunity to specific diseases. This approach is distinct from 'humanized' or other 'fully human' antibody technologies. XBiotech's clinical research and development pipeline addresses a range of unmet medical needs, with programs in therapeutic areas such as oncology, neurology, rheumatology, and anti-infectives. A key focus of its development is on therapies that target interleukin-1α (IL-1α), a substance that can cause harmful inflammation.

Recent filings

Filing Released Lang Actions
ARS
Annual Report
2023-04-28 English
DEFA14A
Regulatory Filings
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
FORM 10-K
Annual Report FY 2022
2023-03-15 English
FORM 3 SUBMISSION
Director's Dealing
2023-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.